Please Wait
Applying Filters...
menu
    • menu
    munit-sa-m-2025-04-14

    Virtual Booth

    Contact Supplier

    Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-04-14

    Virtual Booth

    Contact Supplier

    Menu

    Fenretinide

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    SciTech Announces 2nd FDA Approval of a Phase 1 a/b IND For ST-001
    SciTech Announces 2nd FDA Approval of a Phase 1 a/b IND For ST-001

    08 Apr 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/scitech-development-announces-2nd-fda-approval-of-a-phase-1-ab-ind-for-st-001-new-ind-targets-the-treatment-of-relapsedrefractory-small-cell-lung-cancer-following-its-previous-approval-in-the-treatment-of-t-cell-nhl-302421487.html

    PR NEWSWIRE
    08 Apr 2025
    Share Share
    Laurent Pharmaceuticals reaches agreement with US Cystic Fibrosis Foundation to increase Development Award to $US 5M
    Laurent Pharmaceuticals reaches agreement with US Cystic Fibrosis Foundation to increase Development Award to $US 5M

    14 Mar 2018

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/laurent-pharmaceuticals-reaches-agreement-with-us-cystic-fibrosis-foundation-to-increase-development-award-to-us-5m-676835603.html

    PR NEWSWIRE
    14 Mar 2018
    Share Share
    Laurent Pharmaceuticals Receives FDA and Health Canada Clearance to Initiate APPLAUD Phase 2 Clinical Study of LAU-7b for the Treatment of Cystic Fibrosis
    Laurent Pharmaceuticals Receives FDA and Health Canada Clearance to Initiate APPLAUD Phase 2 Clinical Study of LAU-7b for the Treatment of Cystic Fibrosis

    19 Apr 2017

    // PRESS RELEASE

    http://www.laurentpharma.com/news/63-laurent-pharmaceuticals-receives-fda-and-health-canada-clearance-to-initiate-applaud-phase-2-clinical-study-of-lau-7b-for-the-treatment-of-cystic-fibrosis.html

    PRESS RELEASE
    19 Apr 2017
    Share Share
    Design of controlled release PLGA microspheres for hydrophobic fenretinide
    Design of controlled release PLGA microspheres for hydrophobic fenretinide

    23 May 2016

    // PHARMA-EXCIPIENTS

    http://www.pharma-excipients.ch/2016/05/24/design-of-controlled-release-plga-microspheres-for-hydrophobic-fenretinide/

    PHARMA-EXCIPIENTS
    23 May 2016
    Share Share